SCHRODER INVESTMENT MANAGEMENT GROUP - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 173 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SCHRODER INVESTMENT MANAGEMENT GROUP ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$370,000
-96.8%
7,719
-96.9%
0.00%
-96.0%
Q1 2020$11,619,000
+303.7%
245,497
+412.5%
0.02%
+400.0%
Q4 2019$2,878,000
+1214.2%
47,905
+1185.0%
0.01%
Q3 2017$219,0003,7280.00%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 113,737$3,2270.98%
Smith, Graham & Co., Investment Advisors, LP 236,883$6,720,3710.82%
Capital Impact Advisors, LLC 13,607$386,0310.47%
TANG CAPITAL MANAGEMENT LLC 80,000$2,269,6000.34%
BRANDES INVESTMENT PARTNERS, LP 545,050$15,463,0690.33%
Watershed Asset Management, L.L.C. 9,496$269,4020.33%
Jackson Creek Investment Advisors LLC 25,164$7140.30%
SummerHaven Investment Management, LLC 18,178$515,7100.30%
Virtus Fund Advisers, LLC 1,117$31,6890.22%
Virtus Investment Advisers, Inc. 7,308$207,3280.14%
View complete list of EAGLE PHARMACEUTICALS INC shareholders